Immunotech Biopharm Ltd

HKEX:6978.HK

1.6 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018
Operating Activities:
Net Income -335.479-321.095-354.615-439.129-109.054-34.888
Depreciation & Amortization 53.39944.07121.00513.78210.9454.513
Deferred Income Tax 0017.7123.739-5.7690
Stock Based Compensation 04.28548.946151.7030.4050.405
Change In Working Capital 12.30845.09419.073-29.3483.305-8.953
Accounts Receivables 0.25600000
Inventory 2.2893.653-6.8910.835-2.519-1.665
Accounts Payables 000000
Other Working Capital 9.76341.44125.964-30.1835.824-7.288
Other Non Cash Items 106.14346.723-6.77215.5884.699-4.751
Operating Cash Flow -163.629-180.922-254.653-263.665-95.469-44.079
Investing Activities:
Investments In Property Plant And Equipment -19.579-96.567-181.239-75.672-21.023-35.07
Acquisitions Net 0000019.588
Purchases Of Investments -100-152.029-150.085-131.9690-50
Sales Maturities Of Investments 0230.0850046.77714.899
Other Investing Activites 2.98241.8923.1183.574-0.0130.183
Investing Cash Flow -116.59723.381-328.206-204.06725.741-50.4
Financing Activities:
Debt Repayment 282.44110085.5870
Common Stock Issued 0001,137.1110.0030
Common Stock Repurchased 0000-6.8130
Dividends Paid 0000-0.929-33.567
Other Financing Activities -8.519-37.06-10.999-82.423132.551214.447
Financing Cash Flow 273.922-36.06-10.9991,054.688217.209214.447
Other Information:
Effect Of Forex Changes On Cash 0.0170.648-0.127-23.8176.4344.974
Net Change In Cash -6.287-192.953-593.985563.139153.915124.942
Cash At End Of Period 52.16158.448251.401845.386282.247128.332